Zobrazeno 1 - 10
of 356
pro vyhledávání: '"Sun‐Young Kong"'
Autor:
Yoon-Jung Choi, Younju Park, Boyoung Park, Heejung Chae, So-Youn Jung, Kum Hei Ryu, Myong Cheol Lim, Soo Jin Park, Yoon Jung Chang, Sun-Young Kong
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract The BRCA1/2 pathogenic variant (PV) increases the risk of breast and ovarian cancer; thus, risk-reducing salpingo-oophorectomy (RRSO) and mastectomy (RRM) are recommended. We evaluated the effects of the graphical display of cancer risk comp
Externí odkaz:
https://doaj.org/article/2ee6cbc002a04e1f9b601e73b1e8a5b2
Autor:
Min-Chae Kang, Sun-Young Kong, Sang-Yoon Park, Seog-Yun Park, Eun-Gyeong Lee, Chong Woo Yoo, Yun Hwan Kim, Hyeji Kim, Wonyoung Choi
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
SMARCA4 (BRG1) is a core unit of the SWI/SNF complex, regulating gene transcription through chromatin remodeling. Germline SMARCA4 variants have been reported to be associated with various malignancies. Here, we report the first case of extraskeletal
Externí odkaz:
https://doaj.org/article/ddedf15e974e4348afb5defdee1a0d66
Autor:
Hae In Bang MD, Ja Young Lee MD, Hyun-Young Kim MD, Saeam Shin MD, Myung Hyun Nam MD, In-Suk Kim MD, Ji Myung Kim MD, Jong-Hyun Yoon MD, Myung-Geun Shin MD, Sang Mee Hwang MD, Sun-Young Kong MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
The objective of this survey was to gain a real-world perspective on coagulation testing by evaluating the availability of various coagulation laboratory tests, assessing specific analytic and postanalytic steps in clinical laboratories in Korea. Par
Externí odkaz:
https://doaj.org/article/b35624228cc44cbcba40af69349d166f
Autor:
Mingyun Bae, Gyuhee Kim, Tae-Rim Lee, Jin Mo Ahn, Hyunwook Park, Sook Ryun Park, Ki Byung Song, Eunsung Jun, Dongryul Oh, Jeong-Won Lee, Young Sik Park, Ki-Won Song, Jeong-Sik Byeon, Bo Hyun Kim, Joo Hyuk Sohn, Min Hwan Kim, Gun Min Kim, Eui Kyu Chie, Hyun-Cheol Kang, Sun-Young Kong, Sang Myung Woo, Jeong Eon Lee, Jai Min Ryu, Junnam Lee, Dasom Kim, Chang-Seok Ki, Eun-Hae Cho, Jung Kyoon Choi
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Abstract Multi-cancer early detection remains a key challenge in cell-free DNA (cfDNA)-based liquid biopsy. Here, we perform cfDNA whole-genome sequencing to generate two test datasets covering 2125 patient samples of 9 cancer types and 1241 normal c
Externí odkaz:
https://doaj.org/article/df10ed343d5c4d9d913691c7935c3617
Autor:
Danbee Kang, Sooyeon Kim, Hyunsoo Kim, Mangyeong Lee, Sun-Young Kong, Yoon Jung Chang, Sung Hoon Sim, Yeon-Joo Kim, Juhee Cho
Publikováno v:
JMIR Public Health and Surveillance, Vol 9, p e44105 (2023)
BackgroundOver 90% of patients with cancer experience 1 or more symptoms caused directly by cancer or its treatment. These symptoms negatively impact on the completion of planned treatment as well as patients’ health-related quality of life (HRQoL)
Externí odkaz:
https://doaj.org/article/0808c03bf59b4462a0bdf63cce3b8258
Autor:
So‐Youn Jung, Young Ae Kim, Dong‐Eun Lee, Jungnam Joo, Joung Hwan Back, Sun‐Young Kong, Eun Sook Lee
Publikováno v:
Cancer Medicine, Vol 10, Iss 18, Pp 6480-6491 (2021)
Abstract Background As the incidence of breast cancer has increased and the survival rate has improved, supporting the optimal follow‐up strategy has become an important issue. This study aimed to evaluate follow‐up imaging usage after breast can
Externí odkaz:
https://doaj.org/article/d77c7fde17ce4cc790a7b9cead41a136
Autor:
Kieun Bae, Jin Hee Kim, Ja Young Lee, Sun-Young Kong, Yun-Hee Kim, Sunshin Kim, Kyong-Ah Yoon
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
We previously reported CD63-BCAR4 fusion as a novel oncogene that significantly enhanced cell migration and metastasis in lung cancer. To identify effective inhibitors of metastatic activity induced by BCAR4 fusion, we screened a drug library of 381
Externí odkaz:
https://doaj.org/article/efd9a0f310f74e66b00a30313c8d7abf
Autor:
Xiang Shu, Jirong Long, Qiuyin Cai, Sun-Seog Kweon, Ji-Yeob Choi, Michiaki Kubo, Sue K. Park, Manjeet K. Bolla, Joe Dennis, Qin Wang, Yaohua Yang, Jiajun Shi, Xingyi Guo, Bingshan Li, Ran Tao, Kristan J. Aronson, Kelvin Y. K. Chan, Tsun L. Chan, Yu-Tang Gao, Mikael Hartman, Weang Kee Ho, Hidemi Ito, Motoki Iwasaki, Hiroji Iwata, Esther M. John, Yoshio Kasuga, Ui Soon Khoo, Mi-Kyung Kim, Sun-Young Kong, Allison W. Kurian, Ava Kwong, Eun-Sook Lee, Jingmei Li, Artitaya Lophatananon, Siew-Kee Low, Shivaani Mariapun, Koichi Matsuda, Keitaro Matsuo, Kenneth Muir, Dong-Young Noh, Boyoung Park, Min-Ho Park, Chen-Yang Shen, Min-Ho Shin, John J. Spinelli, Atsushi Takahashi, Chiuchen Tseng, Shoichiro Tsugane, Anna H. Wu, Yong-Bing Xiang, Taiki Yamaji, Ying Zheng, Roger L. Milne, Alison M. Dunning, Paul D. P. Pharoah, Montserrat García-Closas, Soo-Hwang Teo, Xiao-ou Shu, Daehee Kang, Douglas F. Easton, Jacques Simard, Wei Zheng
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
In breast cancer, genome-wide associations studies (GWAS) have highlighted loci associated with disease risk. Here, the authors perform a meta-analysis of GWAS data from Asian populations, discovering 31 potential new risk loci, 10 of which are valid
Externí odkaz:
https://doaj.org/article/532b4d0876ab46de877da9effc1e588e
Autor:
Kyong-Ah Yoon, Sang Myung Woo, Yun-Hee Kim, Sun-Young Kong, Min Kyoung Lee, Sung-Sik Han, Tae Hyun Kim, Woo Jin Lee, Sang-Jae Park
Publikováno v:
Gut and Liver, Vol 13, Iss 6, Pp 683-689 (2019)
Background/Aims Pancreatic ductal adenocarcinoma (PDA) is associated with an extremely poor prognosis. This study assessed the genetic diversity among patients with PDA and compared their mutational profiles before and after treatment. Methods : Tumo
Externí odkaz:
https://doaj.org/article/bbebc9a766004df99cc971cce31a6666
Autor:
Chung Ryul Oh, Sun-Young Kong, Hyeon-Su Im, Hwa Jung Kim, Min Kyeong Kim, Kyong-Ah Yoon, Eun-Hae Cho, Ja-Hyun Jang, Junnam Lee, Jihoon Kang, Sook Ryun Park, Baek-Yeol Ryoo
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Although sorafenib is the global standard first-line systemic treatment for unresectable hepatocellular carcinoma (HCC), it does not have reliable predictive or prognostic biomarkers. Circulating cell-free DNA (cfDNA) has shown pr
Externí odkaz:
https://doaj.org/article/d4b0634ea94245ef911858c5c705d2ab